The Korean government is busy preparing measures to protect the Korean industry from the Executive Order signed in the US by President Biden to launch a National Biotechnology and Biomanufacturing Initiative that focuses on research and manufacturing of pharmaceuticals within the United States,

As the US government has not yet finalized its direction in regulating other countries on bio-related matters, the Korean government has also not yet decided on specific measures other than to actively utilize the Korea-US dialogue channel. However, the authorities are planning to seek countermeasures by increasing the frequency of joint ministerial meetings after holding an industry inspection meeting in rel